logo

For the Inventor, By the Inventor

Waukegan, IL, United States of America

Paul Kurath

This inventor holds 10 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1978-1982.

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 44(Granted Patents)


Company Filing History:

goldMedal10 out of 4,186 
 
Abbott Laboratories Corporation
 patents

Years Active: 1978-1982

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4338309 - 4',5'-Dihydro-antibiotic AX-127B-1; (1982-07-06),
2. 4338308 - 4-N-.beta.-Lysyl-2'-N-des-.beta.-lysyl antibiotic AX-127B-1 and the (1982-07-06),
3. 4338307 - 2'-N-Des-.beta.-lysyl antibiotic AX-127B-1 and 4-N-acyl and alkyl (1982-07-06),
4. 4231924 - 4-N-Acylfortimicin B derivatives and the chemical conversion of (1980-11-04),
5. 4188319 - 4-N-Acylfortimicin B derivatives and the chemical conversion of (1980-02-12),
6. 4183920 - 4-N-Acyl, 2'-N-acyl and 4,2'-N,N'-diacylfortimicin E derivatives (1980-01-15),
7. 4174312 - 4-N-acylfortimicin B derivatives and the chemical conversion of (1979-11-13),
8. 4173564 - 4-N-acylfortimicin B derivatives and the chemical conversion of (1979-11-06),
9. 4155902 - 4-N-acylfortimicin B derivatives and the chemical conversion of (1979-05-22),
10. 4091032 - 4-N-acylfortimicin B derivatives and the chemical conversion of (1978-05-23),

Title: The Innovative Journey of Paul Kurath: A Pioneer in Antibiotic Development

Introduction: Paul Kurath is an accomplished inventor based in Waukegan, Illinois, recognized for his significant contributions to the field of antibiotics. With a remarkable portfolio of 10 patents, his work primarily focuses on developing novel antibiotic compounds with enhanced efficacy.

Latest Patents: Among his latest innovations are the patents for 2'-N-Des-β-lysyl antibiotic AX-127B-1 and 4-N-acyl and alkyl - 2'-N-Des-β-lysyl antibiotic AX-127B-1, along with their derivatives. These compounds are designed as intermediates in the synthesis of 3-O-demethyl antibiotic AX-127B-1 and are not only useful in this capacity but also serve as broad-spectrum antibacterial agents. Furthermore, his inventions, including 4-N-β-Lysyl-2'-N-des-β-lysyl antibiotic AX-127B-1 and its pharmaceutically acceptable salts, further highlight his commitment to advancing antibiotic therapies.

Career Highlights: Paul has demonstrated a consistent dedication to innovation throughout his career. His current affiliation with Abbott Laboratories Corporation has allowed him to contribute significantly to the research and development of antibiotic solutions. His inventions have the potential to transform treatment options for bacterial infections, addressing some of the pressing challenges in modern medicine.

Collaborations: Throughout his journey, Paul Kurath has worked alongside notable colleagues such as John S. Tadanier and Jerry R. Martin. These collaborations have fostered an environment of creativity and innovation, leading to groundbreaking advancements in antibiotic research.

Conclusion: Paul Kurath's work exemplifies the spirit of innovation and dedication to improving healthcare through the development of new antibiotic therapies. His contributions to the field, embodied in his patents, are poised to leave a lasting impact on the pharmaceutical industry, helping to combat bacterial infections effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…